Suppr超能文献

使用微流控反应器通过自下而上的纳米沉淀技术制备氢化可的松纳米混悬液。

Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors.

作者信息

Ali Hany S M, York Peter, Blagden Nicholas

机构信息

Institute of Pharmaceutical Innovation, School of Pharmacy, University of Bradford, Richmond Road, Bradford BD7 1DP, United Kingdom.

出版信息

Int J Pharm. 2009 Jun 22;375(1-2):107-13. doi: 10.1016/j.ijpharm.2009.03.029. Epub 2009 Apr 5.

Abstract

In this work, the possibility of bottom-up creation of a relatively stable aqueous hydrocortisone nanosuspension using microfluidic reactors was examined. The first part of the work involved a study of the parameters of the microfluidic precipitation process that affect the size of generated drug particles. These parameters included flow rates of drug solution and antisolvent, microfluidic channel diameters, microreactors inlet angles and drug concentrations. The experimental results revealed that hydrocortisone nano-sized dispersions in the range of 80-450 nm were obtained and the mean particle size could be changed by modifying the experimental parameters and design of microreactors. The second part of the work studied the possibility of preparing a hydrocortisone nanosuspension using microfluidic reactors. The nano-sized particles generated from a microreactor were rapidly introduced into an aqueous solution of stabilizers stirred at high speed with a propeller mixer. A tangential flow filtration system was then used to concentrate the prepared nanosuspension. The nanosuspension produced was then characterized using photon correlation spectroscopy (PCS), Zeta potential measurement, transmission electron microscopy (TEM), differential scanning calorimetry (DSC) and X-ray analysis. Results showed that a narrow sized nanosuspension composed of amorphous spherical particles with a mean particle size of 500+/-64 nm, a polydispersity index of 0.21+/-0.026 and a zeta potential of -18+/-2.84 mV was obtained. Physical stability studies showed that the hydrocortisone nanosuspension remained homogeneous with slight increase in mean particle size and polydispersity index over a 3-month period.

摘要

在这项工作中,研究了使用微流控反应器自下而上制备相对稳定的氢化可的松水纳米混悬液的可能性。工作的第一部分涉及对影响生成药物颗粒大小的微流控沉淀过程参数的研究。这些参数包括药物溶液和抗溶剂的流速、微流控通道直径、微反应器入口角度和药物浓度。实验结果表明,获得了粒径在80 - 450 nm范围内的氢化可的松纳米分散体,并且通过改变实验参数和微反应器设计可以改变平均粒径。工作的第二部分研究了使用微流控反应器制备氢化可的松纳米混悬液的可能性。将微反应器中生成的纳米颗粒迅速引入到用螺旋桨搅拌器高速搅拌的稳定剂水溶液中。然后使用切向流过滤系统对制备的纳米混悬液进行浓缩。接着使用光子相关光谱法(PCS)、Zeta电位测量、透射电子显微镜(TEM)、差示扫描量热法(DSC)和X射线分析对所制备的纳米混悬液进行表征。结果表明,获得了一种粒径分布窄的纳米混悬液,其由平均粒径为500±64 nm、多分散指数为0.21±0.026且Zeta电位为 - 18±2.84 mV的无定形球形颗粒组成。物理稳定性研究表明,在3个月的时间内,氢化可的松纳米混悬液保持均匀,平均粒径和多分散指数略有增加。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验